Latest filing published 22 Apr 2026 for 恩华药业.
孙彭生: trading record in brief
孙彭生, listed as board member, appears in our data through filings on 恩华药业 shares, published by SSE / SZSE (CSRC). Over a trading history stretching from 16 June 2025 to 22 April 2026, the count stands at 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €1.1M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at 1 purchase and no sales.
The newest entry dates from 22 April 2026: an open-market purchase of €534k, in 恩华药业. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Companies and markets linked to 孙彭生
Open company profiles for insider transactions, fundamentals and analyst consensus when available.